Hygiene3Plasma

Novaerus - airborne infection control

  • Fights aerial dissemination of pathogens, VOCs (Volatile Organic Compounds) and consistently insanitary odors [8; 15-19]
  • Aims closing the infection control loop
  • Uses a patented and safe plasma technology with multiple methods to eliminate pathogens, VOCs and odors [11-14]
    • Electron Bombardment
    • Photon Irradiation
    • Electroporation Oxidation & Etching
 

Novaerus NV-200
  • Portable unit: desktop and wall mounted
  • 230V, 50Hz
  • Power consumption: 11 Watts
  • Metal casing in a white anti-bacterial powder coat finish
  • Dimensions:
    29.2 cm (h) x 12.7 cm (w) x 10.2 cm (d)
  • Weight 3.4 kg
  • Air flow volume: 50 m³/h
  • For rooms up to 20 m²


 

Novaerus NV-800
  • Wall or stand mounted unit
  • 230V, 50Hz
  • Power consumption: 25 Watts
  • Metal casing in a white anti-bacterial powder coat finish
  • Dimensions:
    36.5 cm (h) x 36.5 cm (w) x 11.5 cm (d)
  • Weight 4.5 kg
  • Air flow volume:
  • Setting I = 220 m³/h
  • Setting II = 260 m³/h
  • For rooms up to 50 m²

* The above-mentioned values in the graph can differ from the optimum specified value due to the specific conditions during operation. The different studies indicate the general efficacy with a possible broader spectrum.

References

  1. von Lengerke et al., 2016, Psychologie der Händehygiene-Compliance: Von der Motivation zum Verhalten. Krankenhaushygiene up2date, 11(02): 135-150.
  2. Christiansen et al., 2004, Anforderungen an die Hygiene bei der Reinigung und Desinfektion von Flächen –Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert-Koch-Institut (RKI). Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 2004.47: 51-61
  3. Kowalski, 2007, Air-treatment systems for controlling hospital-acquired infections. HPAC Engineering, 79(1): 28-48
  4. Fernstrom & Goldblatt, 2013, Aerobiology and its role in the transmission of infectious diseases. Journal of pathogens: 1-13
  5. Brachman, 1971, Hospital-acquired infection—airborne or not? Eds., American Hospital Association, Chicago, Ill, USA: 189-192
  6. Tang et al., 2006, Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. Journal of Hospital Infection, 64(2): 100-114
  7. King et al., 2013, Bioaerosol deposition in single and two-bed hospital rooms: A numerical and experimental study. Building and Environment, 59: 436-447
  8. James, 2010, Evaluation of Air Decontamination Technology: NOVAERUS NV-100 Airborne Infection Control Technology, Study Report: Smart Solutions for HCAI
  9. RB Health Partners, 2015, Manchester Manor Implements State of the Art Novaerus Technology to Protect Residents and Reduce the Rate of Nosocomial Infections and Readmissions, RB Health Partners, Inc., March, 2015: 1-3
  10. RB Health Partners, 2014, Hialeah Nursing and Rehabilitation Center Combines Technology and Best Practices to Improve Infection Control Specific to C.diff, RB Health Partners, Inc., 24. Juni 2014: 1-5
  11. Romero-Mangado et al., 2016, Morphological and chemical changes of aerosolized E. coli treated with a dielectric barrier discharge. Biointerphases, 11(1), 011009: 1-8
  12. Gallagher et al., 2007, Rapid inactivation of airborne bacteria using atmospheric pressure dielectric barrier grating discharge. IEEE Transactions on Plasma Science, 35(5): 1501-1510
  13. Laroussi & Leipold, 2004, Evaluation of the roles of reactive species, heat, and UV radiation in the inactivation of bacterial cells by air plasmas at atmospheric pressure. International Journal of Mass Spectrometry, 233(1): 81-86
  14. Daniels, 2013, Novaerus Gaseous Plasma Discharge Technology for Air Disinfection: Review and Discussion.National Centre for Plasma Science and Technology, Dublin City University, Ireland
  15. Dobbin & Soberon, 2015, Novaerus Technical Report No. Technical Report No. NV-0050, West Gables Health Care Center, Miami, FL,  USA
  16. Dobbin, 2016, Novaerus Technical Report No. Technical Report No. NV-0061, Professional Drive Dental, Northfield, MN,  USA
  17. Novaerus Group Ltd., 2014, Clinical Trial in two Dialysis Facilities, internal report.
  18. Dobbin, 2016, Novaerus Technical Report No. NV-0060, Mount Olivet Care View Home, South Minneapolis, MN,  USA
  19. Egerszegi, 2015, Report, Pulmology, Uzsoki hospital, Budapest, Hungary
  20. RB Health Partners, 2014, Regents Park Combines Technology, Best Practices to Improve Infection Control, RB Health Partners, Inc., 16. April 2014: 1-2
  21. RB Health Partners, 2013, Page Rehabilitation and Health Center Combines Technology, Best Practices to Improve Infection Control, RB Health Partners, Inc., 3. December 2013: 1-2